Mostrando 2 resultados de: 2
Subtipo de publicación
Article(2)
Área temáticas
Farmacología y terapéutica(2)
Enfermedades(1)
Fisiología humana(1)
Química y ciencias afines(1)
Origen
scopus(2)
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
ArticleAbstract: The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased drastically due to the globPalabras claves:AAV, CPT1A, fatty-acid oxidation, Gene therapy, hepatic steatosis, lipid biomarker, obesityAutores:Alonso S., Bartrons R., Calderón-Domínguez M., Casals N., Casas J., Escolà-Gil J.C., Frühbeck G., Fucho R., Herrero L., Llorente-Cortes V., Mera P., Mir J.F., Montironi C., Rodríguez A., Salvador J., Sánchez-Infantes D., Sandra Recalde, Sebastián D., Serra D., Soler-Vázquez M.C., Valentí V., Weber M., Zorzano A.Fuentes:scopusSynthesis of new carnitine palmitoyltransferase I inhibitors derivatives of C75
ArticleAbstract: Carnitine Palmitoyltransferase (CPT1) is an enzyme that catalyzes the transport of fatty acids fromPalabras claves:C75, Carnitine palmitoyltransferase 1 inhibitor, CPT1, α-Methylene-γ-butyrolactonesAutores:Alicia Venegas, Ariza J., Garcia J., Herrero L., Makowski K., Marta López, Mera P., Serra D.Fuentes:scopus